New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress
Go back to New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress| BARNES GROUP, Inc. (NYSE: B) | Delayed: 40.14 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.14 | 52 Week High | $44.27 | |||
| Open | $40.14 | 52 Week Low | $30.07 | |||
| Day High | $40.14 | P/E | 30.64 | |||
| Day Low | $40.14 | EPS | $1.31 | |||
| Volume | 458,834 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 21.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.47 | 52 Week High | $8.73 | |||
| Open | $21.47 | 52 Week Low | $2.86 | |||
| Day High | $21.47 | P/E | N/A | |||
| Day Low | $21.47 | EPS | $-3.82 | |||
| Volume | 30 | |||||
